Unknown

Dataset Information

0

A penetratin-derived peptide reduces the membrane permeabilization and cell toxicity of α-synuclein oligomers: A penetratin-derived peptide against α-synuclein oligomers.


ABSTRACT: Parkinson's Disease (PD) is a neurodegenerative movement disorder associated with the intracellular aggregation of α-synuclein (α-syn). Cytotoxicity is mainly associated with the oligomeric species (αSOs) formed at early stages in α-syn aggregation. Consequently, there is an intense focus on the discovery of novel inhibitors such as peptides to inhibit oligomer formation and toxicity. Here, using peptide arrays, we identified nine peptides with high specificity and affinity for αSOs. Of these, peptides p194, p235, and p249 diverted α-syn aggregation from fibrils to amorphous aggregates with reduced β-structures and increased random coil content. However, they did not reduce αSO's cytotoxicity and permeabilization of large anionic unilamellar vesicles (LUV). In parallel, we identified a non-self-aggregating peptide (p216), derived from the cell-penetrating peptide penetratin, which showed 12-fold higher binding affinity to αSOs than to α-syn monomers (Kdapp 2.7 and 31.2 μM, respectively). p216 reduced αSOs-induced LUV membrane permeability at 10-1-10-3 mg/ml by almost 100%, was not toxic to SH-SY5Y cells, and reduced αSOs cytotoxicity by about 20%. We conclude that p216 is a promising starting point from which to develop peptides targeting toxic αSOs in PD.

SUBMITTER: Pirhaghi M 

PROVIDER: S-EPMC9791135 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

A penetratin-derived peptide reduces the membrane permeabilization and cell toxicity of α-synuclein oligomers.

Pirhaghi Mitra M   Frank Signe Andrea SA   Alam Parvez P   Nielsen Janni J   Sereikaite Vita V   Gupta Arpit A   Strømgaard Kristian K   Andreasen Maria M   Sharma Deepak D   Saboury Ali Akbar AA   Otzen Daniel Erik DE  

The Journal of biological chemistry 20221110 12


Parkinson's disease is a neurodegenerative movement disorder associated with the intracellular aggregation of α-synuclein (α-syn). Cytotoxicity is mainly associated with the oligomeric species (αSOs) formed at early stages in α-syn aggregation. Consequently, there is an intense focus on the discovery of novel inhibitors such as peptides to inhibit oligomer formation and toxicity. Here, using peptide arrays, we identified nine peptides with high specificity and affinity for αSOs. Of these, peptid  ...[more]

Similar Datasets

| S-EPMC11334933 | biostudies-literature
| S-EPMC2276244 | biostudies-literature
| S-EPMC2900531 | biostudies-literature
| S-EPMC5233976 | biostudies-literature
| S-EPMC11238581 | biostudies-literature
| S-EPMC4049638 | biostudies-literature
| S-EPMC2695042 | biostudies-literature
| S-EPMC8199589 | biostudies-literature
| S-EPMC10513202 | biostudies-literature
| S-EPMC4601656 | biostudies-literature